Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Capsida Biotherapeutics
Biotech
AbbVie exercises $40M option for Capsida-partnered gene therapy
AbbVie decided to opt-in based on data showing that Capsida’s viral capsids were able to deliver AbbVie’s gene therapy to the brains of primates.
Darren Incorvaia
Jan 7, 2025 10:45am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
VC launches biotech fund with $450M and 'recipe for success'
Jul 17, 2023 12:26pm
Capsida cuts staff even with AbbVie, Lilly deals on the books
Jul 14, 2023 12:32pm
AbbVie pays $70M to expand Capsida collab into eye disease
Feb 23, 2023 5:00am
Lilly pays $55M to join AbbVie on AAV specialist's partner list
Jan 4, 2023 7:45am
